Chromocell Therapeutics | 424B3:募资说明书
Chromocell Therapeutics | 10-Q:季度报表
Chromocell Therapeutics | 424B3:募资说明书
Chromocell Therapeutics | 424B3:募资说明书
Chromocell Therapeutics | 424B3:募资说明书
Chromocell Therapeutics | POS EX:招股信息更正说明
Chromocell Therapeutics | 10-K:年度报表
Chromocell Therapeutics | S-8:员工福利计划证券登记
Chromocell Therapeutics | 8-K:重大事件
Chromocell Therapeutics | NT 10-K:其他
Chromocell Therapeutics | 8-K:重大事件
Chromocell Therapeutics | 8-K:重大事件
Chromocell Therapeutics | 8-K:重大事件
Chromocell Therapeutics | 4/A:持股变动声明(修正)-董事 Friedberg Ezra M
Chromocell Therapeutics | SC 13G:超过5%持股股东披露文件-Boswell Prayer Ltd(8.2%),Rochelle Gross(8.2%)
Chromocell Therapeutics | SC 13G:超过5%持股股东披露文件-Benuvia Operations, LLC(6.7%),Darwin Richardson(6.7%)
Chromocell Therapeutics | SC 13G:超过5%持股股东披露文件-Aperture Healthcare Ventures Ltd.(7.7%),Waxcap Inc.(0.7%)
Chromocell Therapeutics | SC 13G:超过5%持股股东披露文件-Motif Pharmaceuticals Ltd.(8.4%)
Chromocell Therapeutics | SC 13G:超过5%持股股东披露文件-AME Equities LLC(6.4%),Ruth Friedman(6.4%)
Chromocell Therapeutics | SC 13G:超过5%持股股东披露文件-3i, LP(5.5%),3i Management LLC(5.5%)等
暂无数据